Get ready for a new standard in surgical performance!
TransEnterix is now Asensus Surgical.
Our Strategic Intent
At Asensus, we’re digitizing the interface between the surgeon and patient, pioneering a new standard of surgery for increased control, less variability and consistently superior outcomes.
Asensus, Inc. – Founded in 2006
At Asensus, we are digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through a new category of care called Digital Laparoscopy. Digitizing the interface enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and allows us to address the current clinical, cognitive and economic shortcomings in surgery. The system features the first machine vision system for use in robotic surgery which is powered by the new Intelligent Surgical Unit™ (ISU™) that enables augmented intelligence in surgery. The Senhance Surgical System brings the benefits of Digital Laparoscopy to patients around the world while staying true to the principles of value-based healthcare. Now available for sale in the US, the EU, Japan, Russia, and select other countries.
Previously, Asensus also developed the SPIDER device and the SurgiBot System.